发明名称 |
Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses |
摘要 |
This invention involves two fields of photoelectron information materials and pharmaceuticals, especially refers to the self-assembly of conducting photoluminescence nanomedicine crystals and thin films and their preparation processes. In the invention, self-assembling unitary, binary, ternary and quaternary complexes of an antioxidase antioxidant, an agonist of the β-adrenergic receptors, an agonist of the P2-purinergic receptors and an antagonist of benzalkonium-typed calcium channels is to employ an interaction of inelastic electron tunneling, which possesses photoelectron properties of inelastic electron tunneling and photoluminescence with the central wavelength ˜500 nm and the wavelength wide ˜200 nm in the size-controlled square or cubic geometrical complexes. The invention is not only beneficial for drug discovery targeted disease mechanisms, but also profitable for inventions of photoelectron sensing new materials. |
申请公布号 |
US8889188(B2) |
申请公布日期 |
2014.11.18 |
申请号 |
US200511813265 |
申请日期 |
2005.12.29 |
申请人 |
Zhongshan Hospital, Fudan University |
发明人 |
Fang Yan |
分类号 |
A61K9/14;A61K38/44;A61K9/51;A61K31/137;A61K31/52;A61K45/06 |
主分类号 |
A61K9/14 |
代理机构 |
Hamre, Schumann, Mueller & Larson, P.C. |
代理人 |
Hamre, Schumann, Mueller & Larson, P.C. |
主权项 |
1. A low power three-dimensional (3D) self-assembled conducting photoluminescent nanomedicine, comprising:
3D unitary, binary, ternary, and quaternary nanomedicine crystals of isoprenaline, adenosine triphosphate, verapamil, and superoxide dismutase, in a L16(2)15 test protocol that includes four unitary groups, six binary groups, four ternary groups and one quaternary group at two levels of 0 and 1, and a L9(3)4 test protocol that includes nine quaternary groups at three levels of 1, 2 and 3, the 3D unitary, binary, ternary, and quaternary nanomedicine crystals disposed on a substrate of graphite and/or silicon, wherein the 3D unitary, binary, ternary, and quaternary nanomedicine crystals have a length from 400 nm to 1000 nm, a width from 400 nm to 1000 nm, and a height from 0.3 nm to 95 nm, and the low power three-dimensional (3D) self-assembled conducting photoluminescent nanomedicine has an inelastic electron tunneling property, a conducting property having a range of 1-8 μeV, and a photoluminescent property having a maximum photoluminescence intensity at 2000 absorbance units, a photoluminescence bandwidth covering 450-750 nm, and a central photoluminescence peak being located around 550 nm after subtraction of a background signal. |
地址 |
Shanghai CN |